Across the five districts, recurring concerns included suspected substandard quality, absent or non-functional laboratories, a lack of qualified chemists, packaging and labelling violations, licensing... .
Food and Drug Administration (FDA) on Friday, seeking approval of rivoceranib in combination with camrelizumab as a first-line treatment for liver cancer. The resubmission follows an FDA complete ...
FDA approved Lisraya, an oral TYK2/JAK1 inhibitor, for the treatment of adults with dermatomyositis. It became the first FDA-approved oral treatment specifically indicated for this condition, addressing a significant unmet medical need.
Separate FDA submissions report mean small-bowel capsule review-time reductions of 88.6% with ProScan-assisted reading and 24.7% with a recently cleared comparator AI-assisted workflow ....
The USFood and Drug Administration (FDA) is proposing to expand a controversial loophole to allow some of the world’s most toxic chemicals to be added directly to food without a safety review ... The FDA did not respond to a request for comment.
Gias Foods, Inc ... The contamination "can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems," according to the notice published by the FDA...Sign up ... Making top 50.